DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis. [electronic resource]
- The British journal of dermatology Jul 2014
- 39-47 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2133
10.1111/bjd.12913 doi
Adult Antimetabolites--pharmacology Azacitidine--pharmacology CD4-Positive T-Lymphocytes--metabolism DNA Methylation--physiology Down-Regulation Female Forkhead Transcription Factors--metabolism Humans Male Scleroderma, Systemic--immunology T-Lymphocytes, Regulatory--drug effects